Literature DB >> 34853061

The Use of Serological Tests in the Care of Patients with Lupus Nephritis.

Isabelle Ayoub1, Brad H Rovin2.   

Abstract

Entities:  

Keywords:  auto-antibodies; complement system; lupus nephritis; serologies

Mesh：

Year:  2021        PMID： 34853061      PMCID： PMC8823947          DOI： 10.2215/CJN.13431021

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  11 in total

1.  Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE.

Authors:  David S Pisetsky; Diane M Spencer; Peter E Lipsky; Brad H Rovin
Journal:  Ann Rheum Dis       Date:  2018-02-09       Impact factor: 19.103

2.  Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis.

Authors:  Ana Malvar; Valeria Alberton; Bruno Lococo; Matias Ferrari; Pamela Delgado; Haikady N Nagaraja; Brad H Rovin
Journal:  Kidney Int       Date:  2019-08-20       Impact factor: 10.612

3.  Prospective validation of a novel renal activity index of lupus nephritis.

Authors:  G Gulati; M R Bennett; K Abulaban; H Song; X Zhang; Q Ma; S V Brodsky; T Nadasdy; C Haffner; K Wiley; S P Ardoin; P Devarajan; J Ying; B H Rovin; H I Brunner
Journal:  Lupus       Date:  2016-12-19       Impact factor: 2.911

4.  Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis.

Authors:  Juan M Mejia-Vilet; Xiaolan L Zhang; Cristino Cruz; Mayra L Cano-Verduzco; John P Shapiro; Haikady N Nagaraja; Luis E Morales-Buenrostro; Brad H Rovin
Journal:  J Am Soc Nephrol       Date:  2020-04-16       Impact factor: 10.121

5.  The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.

Authors:  D J Birmingham; F Irshaid; H N Nagaraja; X Zou; B P Tsao; H Wu; C Y Yu; L A Hebert; B H Rovin
Journal:  Lupus       Date:  2010-07-06       Impact factor: 2.911

6.  The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort.

Authors:  L Durcan; M Petri
Journal:  Semin Arthritis Rheum       Date:  2020-06-30       Impact factor: 5.532

Review 7.  The intricate role of complement component C4 in human systemic lupus erythematosus.

Authors:  Yan Yang; Erwin K Chung; Bi Zhou; Karl Lhotta; Lee A Hebert; Daniel J Birmingham; Brad H Rovin; C Yung Yu
Journal:  Curr Dir Autoimmun       Date:  2004

8.  A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy.

Authors:  Marcelo De Rosa; Francisco Azzato; Jorge E Toblli; Graciela De Rosa; Federico Fuentes; Haikady N Nagaraja; Ryan Nash; Brad H Rovin
Journal:  Kidney Int       Date:  2018-07-23       Impact factor: 10.612

9.  A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis.

Authors:  Brad H Rovin; Richard Furie; Y K Onno Teng; Gabriel Contreras; Ana Malvar; Xueqing Yu; Beulah Ji; Yulia Green; Tania Gonzalez-Rivera; Damon Bass; Jennifer Gilbride; Chun-Hang Tang; David A Roth
Journal:  Kidney Int       Date:  2021-09-22       Impact factor: 10.612

10.  When and How Is It Possible to Stop Therapy in Patients with Lupus Nephritis: A Narrative Review.

Authors:  Gabriella Moroni; Giulia Frontini; Claudio Ponticelli
Journal:  Clin J Am Soc Nephrol       Date:  2021-06-23       Impact factor: 8.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.